The Pharma Closeout

THE PHARMA CLOSEOUTManage supplier listing

Long-history pharma/biotech business-development deal database with a proprietary two-axis grading layer. Deal records span the early 1990s to 2026 and carry: announcement date, both counterparties, deal structure class (LICENSE / CO-DEV / ASSET / M&A / TAKE-PRIV), disclosed total value, therapeutic area, lead assets, deal status, plus the vendor's own scores — a Critic Score (deal-day market sentiment, built from announcement-week coverage in at least four independent sources) and an Outcome Score (how the deal actually aged, graded five years post-close on strategic rationale, financial impact and pipeline outcomes). The derived Hype Gap (Outcome minus Critic) and acquirer-level track records computed over completed deals only are the distinctive assets.